Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.
Ontology highlight
SUBMITTER: Momotow J
PROVIDER: S-EPMC6919467 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA